13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)

13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)
Product Description

Active immunization for the prevention of invasive diseases (including bacteremic pneumonia, meningitis, sepsis, bacteremia, etc.) caused by Streptococcus pneumoniae serotypes of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants and children from 2 months (minimum 6 weeks) to 5 years of age.

Read more Show less

CanSino Biologics Inc.

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    One dose of 0.5 mL, a homogeneous white suspension supplied in pre-filled syringes.
  • Selling Points
    Price; 1.Dual carrier protein(CRM197+TT)2.Robust immunogenicity against globally prevalent serotypes
    3.Less side effect and virus infection
  • Model
    Suspension for injection, for intramuscular use.
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

CanSino Biologics Inc.

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Technology
View company profile

More Products from CanSino Biologics Inc. (2)